Melatonin and the ovary: physiological and pathophysiological implications

Fertility and Sterility

Volumn 92, Issue 1, 2009, Pages 328-343

  Tamura, Hiroshi ^a,b   Nakamura, Yasuhiko ^c   Korkmaz, Ahmet ^a   Manchester, Lucien C ^a   Tan, Dun Xian ^a   Sugino, Norihiro ^b   Reiter, Russel J ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Yamaguchi Grand Medical Center   (Japan)

Author keywords

endometriosis; follicular development; luteal function; Melatonin; oocyte quality; ovulation; PCOS; POF

Indexed keywords

ANDROSTENEDIONE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; AROMATASE; BLEOMYCIN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CISPLATIN; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOPHOSPHAMIDE; CYTOCHROME P450C17; DAUNORUBICIN; DOXORUBICIN; ESTRADIOL; FOLLITROPIN; FOLLITROPIN RECEPTOR; IFOSFAMIDE; LUTEINIZING HORMONE; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN 3 RECEPTOR; MELATONIN RECEPTOR; MESSENGER RNA; PROGESTERONE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; ASTHENIA; CARDIOTOXICITY; CORPUS LUTEUM; ENDOMETRIOSIS; GRANULOSA CELL; HUMAN; METABOLITE; NEUROTOXICITY; NONHUMAN; OOCYTE MATURATION; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE FLUID; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION; PATHOGENESIS; PATHOPHYSIOLOGY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REPRODUCTION; REPRODUCTIVE TOXICITY; STOMATITIS; THROMBOCYTOPENIA;

ANIMALS; CORPUS LUTEUM; FEMALE; FOLLICULAR FLUID; GRANULOSA CELLS; HUMANS; MELATONIN; OOCYTES; OVARIAN FOLLICLE; OVARY; RECEPTORS, MELATONIN; RODENTIA;

EID: 67649084063     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.05.016     Document Type: Article

References (208)

1. Reiter R.J. Melatonin and human reproduction. Ann Med 30 (1998) 103-108
2. Rivara S., Lorenzi S., Mor M., Plazzi P.V., Spadoni G., Bedini A., et al. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models. J Med Chem 48 (2005) 4049-4060
3. Von Gall C., Stehle J.H., and Weaver D.R. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res 309 (2002) 151-162
4. Díaz López B., Díaz Rodríguez E., Urquijo C., and Fernández Alvarez C. Melatonin influences on the neuroendocrine-reproductive axis. Ann N Y Acad Sci 1057 (2005) 337-364
5. Barrett P., Conway S., and Morgan P.J. Digging deep-structure-function relationships in the melatonin receptor family. J Pineal Res 35 (2003) 221-230
6. Dubocovich M.L., Rivera-Bermudez M.A., Gerdin M.J., and Masana M.I. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8 (2003) 1093-1108
7. Yie S.M., Niles L.P., and Younglai E.V. Melatonin receptors on human granulose cell membranes. J Clin Endcrinol Metab 80 (1995) 1747-1749
8. Woo M.M.M., Tai C.J., Kang S.K., Nathwani P.M., Pang S.F., and Leung P.C.K. Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab 86 (2001) 4789-4797
9. Sugino N., Takiguchi S., Kashida S., Karube A., Nakamura Y., and Kato H. Superoxide dismutase expression in the human corpus luteum during the menstrual cycle and in early pregnancy. Mol Hum Reprod 6 (2000) 19-25
10. Agarwal A., Gupta S., and Sharma R.K. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3 (2005) 28
11. Agarwal A., Gupta S., and Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol 18 (2006) 325-332
12. Tan D.X., Manchester L.C., Sainz R.M., Mayo J.C., Leon J., Hardeland R., et al. Interaction between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J Pineal Res 39 (2005) 185-194
13. Reiter R.J., Tan D.X., and Maldonado M.D. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 39 (2005) 215-216
14. Pappolla M.A., Chyan Y.J., Poeggeler B., Frangione B., Wilson G., Ghiso J., et al. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J Neural Transm 107 (2000) 203-231
15. Bonilla E., Valero N., Chacín-Bonilla L., and Medina-Leendertz S. Melatonin and viral infections. J Pineal Res 36 (2004) 73-79
16. Hussain S.A., Khadim H.M., Khalaf B.H., Ismail S.H., Hussein K.I., and Sahib A.S. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J 27 (2006) 1483-1488
17. Lissoni P. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms. Pathol Biol (Paris) 55 (2007) 201-204
18. Ceinos R.M., Chansard M., Revel F., Calgari C., Míguez J.M., and Simonneaux V. Analysis of adrenergic regulation of melatonin synthesis in Siberian hamster pineal emphasizes the role of HIOMT. Neurosignals 13 (2004) 308-317
19. Cassone V.M., and Natesan A.K. Time and time again: the phylogeny of melatonin as a transducer of biological time. J Biol Rhythms 12 (1997) 532-534
20. Brzezinski A., Seibel M.M., Lynch H.J., Deng M.H., and Wurtman R.J. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab 64 (1987) 865-867
21. Rönnberg L., Kauppila A., Leppäluoto J., Martikainen H., and Vakkuri O. Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab 71 (1990) 492-496
22. Nakamura Y., Tamura H., Takayama H., and Kato H. Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production. Fertil Steril 80 (2003) 1012-1016
23. Itoh M.T., Ishizuka B., Kuribayashi Y., Amemiya A., and Sumi Y. Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol Hum Reprod 5 (1999) 402-408
24. Allegra M., Reiter R.J., Tan D.X., Gentile C., Tesoriere L., and Livrea M.A. The chemistry of melatonin's interaction with reactive species. J Pineal Res 34 (2003) 1-10
25. Tan D.X., Reiter R.J., Manchester L.C., Yan M.T., El-Sawi M., Sainz R.M., et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2 (2002) 181-197
26. Reiter R.J., Tan D.X., Gitto E., Sainz R.M., Mayo J.C., Leon J., et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol J Pharmacol 56 (2004) 159-170
27. Rosen J., Than N.N., Koch D., Poeggeler B., Laatsch H., and Hardeland R. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 41 (2006) 374-381
28. Tan D.X., Manchester L.C., Terron M.P., Flores L.J.D., and Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and reactive nitrogen species?. J Pineal Res 42 (2007) 28-42
29. Manda K., Ueno M., and Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 42 (2007) 386-393
30. Barlow-Walden L.R., Reiter R.J., Abe M., Pablos M., Menendez-Pelaez A., Chen L.D., et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 26 (1995) 497-502
31. Pablos M.I., Agapito M.T., Gutierrez R., Recio J.M., Reiter R.J., Barlow-Walden L., et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 19 (1995) 111-115
32. Ozturk G., Coşkun S., Erbaş D., and Hasanoglu E. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn J Physiol 50 (2000) 149-153
33. Liu F., and Ng T.B. Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. Biochem Cell Biochem 78 (2000) 447-453
34. Baydas G., Gursu M.F., Yilmaz S., Canpolat S., Yasar A., Cikim G., et al. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci Lett 323 (2002) 195-198
35. Rodriguez C., Mayo J.C., Sainz R.M., Antolín I., Herrera F., Martín V., et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36 (2004) 1-9
36. Antolín I., Rodríguez C., Saínz R.M., Mayo J.C., Uría H., Kotler M.L., et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 10 (1996) 882-890
37. Tomás-Zapico C., and Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 39 (2005) 99-104
38. Mayo J.C., Sainz R.M., Antoli I., Herrera F., Martin V., and Rodriguez C. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 59 (2002) 1706-1713
39. Mor M., Plazzi P.V., Spadoni G., and Tarzia G. Melatonin. Curr Med Chem 6 (1999) 501-518
40. Reppert S.M. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 12 (1997) 528-531
41. Nosjean O., Ferro M., Coge F., Beauverger P., Henlin J.M., Lefoulon F., et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 275 (2000) 31311-31317
42. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., Tamura H., and Reiter R.J. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance. J Pineal Res 43 (2007) 317-320
43. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev 78 (1998) 687-721
44. Murayama T., Kawashima M., Takahashi T., Yasuoka T., Kuwayama T., and Tanaka K. Direct action of melatonin on hen ovarian granulosa cells to lower responsiveness to luteinizing hormone. Proc Soc Exp Bio 215 (1997) 386-392
45. Tamura H., Nakamura Y., Takiguchi S., Kashida S., Yamagata Y., Sugino N., et al. Melatonin directly suppresses steroid production by preovulatory follicles in the cyclic hamster. J Pineal Res 25 (1998) 135-141
46. Webley G.E., and Leidenberger F. The circadian pattern of melatonin and its positive relationship with progesterone in women. J Clin Endocrinol Metab 63 (1986) 323-328
47. Brzezinski A., Schenker J.G., Fibich T., Laufer N., and Cohen M. Effects of melatonin on progesterone production by human granulosa lutein cells in culture. Fertil Steril 58 (1992) 526-529
48. Yie S.M., Brown G.M., Liu G.Y., Collins J.A., Daya S., Hughes E.G., et al. Melatonin and steroids in human pre-ovulatory follicular fluid: seasonal variations and granulosa cell steroid production. Hum Reprod 10 (1995) 50-55
49. Niles L.P., Wang J., Shen L., Lobb D.K., and Younglai E.V. Melatonin receptor mRNA expression in human granulosa cells. Mol Cell Endocrinol 156 (1999) 107-110
50. Soares Jr. J.M., Masana M.I., Erşahin C., and Dubocovich M.L. Functional melatonin receptors in rat ovaries at various stages of the estrous cycle. J Pharmacol Exp Ther 306 (2003) 694-702
51. Hirshfield A.N. Development of follicles in the mammalian ovary. Int Rev Cytol 124 (1991) 43-101
52. 3H-melatonin in endocrine and nervous tissues and the effects of constant light exposure. J Pharmacol Exp Ther 143 (1964) 314-318
53. Tamura H., Takasaki A., Miwa I., Taniguchi K., Maekawa R., Asada H., et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 44 (2008) 280-287
54. Webb R., Nicholas B., Gong J.G., Campbell B.K., Gutierrez C.G., Garverick H.A., et al. Mechanisms regulating follicular development and selection of the dominant follicle. Reprod Suppl 61 (2003) 71-90
55. Drummond AE. The role of steroids in follicular growth. Reprod Biol Endocrinol 200610;4:16.
56. Hillier S.G., Whitelaw P.F., and Smyth C.D. Follicular oestrogen synthesis: the "two-cell, two-gonadotrophin" model revisited. Mol Cell Endocrinol 100 (1994) 51-54
57. Graham J.D., and Clarke C.L. Physiological action of progesterone in target tissues. Endocrinol Rev 18 (1997) 502-519
58. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery Jr. C.A., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes & Dev 9 (1995) 2266-2278
59. Murray A.A., Gosden R.G., Allison V., and Spears N. Effect of androgens on the development of mouse follicles growing in vitro. J Reprod Fertil 113 (1998) 27-33
60. Billig H., Furuta I., and Hsueh A.J. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 133 (1993) 2204-2212
61. Adriaens I., Jacquet P., Cortvrindt R., Janssen K., and Smitz J. Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis. Toxicology 228 (2006) 333-343
62. Tanavde V.S., and Maitra A. In vitro modulation of steroidogenesis and gene expression by melatonin: a study with porcine antral follicles. Endocrinol Res 29 (2003) 399-410
63. Soares Jr. J.M., Simões M.J., Oshima C.T., Mora O.A., De Lima G.R., and Baracat E.C. Pinealectomy changes rat ovarian interstitial cell morphology and decreases progesterone receptor expression. Gynecol Endocrinol 17 (2003) 115-123
64. Wu C.S., Leu S.F., Yang H.Y., and Huang B.M. Melatonin inhibits the expression of steroidogenic acute regulatory protein and steroidogenesis in MA-10 cells. J Androl 22 (2001) 245-254
65. Poretsky L., Cataldo N.A., Rosenwaks Z., and Giudice L.C. The insulin-related ovarian regulatory system in health and disease. Endocrinol Rev 20 (1999) 535-582
66. Chun S.Y., Billig H., Tilly J.L., Furuta I., Tsafriri A., and Hsueh A.J. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I. Endocrinology 135 (1994) 1845-1853
67. Schaeffer H.J., and Sirotkin A.V. Melatonin and serotonin regulate the release of insulin-like growth factor-I, oxytocin and progesterone by cultured human granulosa cells. Exp Clin Endocrinol Diabetes 105 (1997) 109-112
68. Picinato M.C., Hirata A.E., Cipolla-Neto J., Curi R., Carvalho C.R., Anhê G.F., et al. Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets. J Pineal Res 44 (2008) 88-94
69. Knight P.G., and Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 132 (2006) 191-206
70. Dunkel L., Tilly J.L., Shikone T., Nishimori K., and Hsueh A.J. Follicle-stimulating hormone receptor expression in the rat ovary: increases during prepubertal development and regulation by the opposing actions of transforming growth factors beta and alpha. Biol Reprod 50 (1994) 940-948
71. Hutchinson L.A., Findlay J.K., de Vos F.L., and Robertson D.M. Effects of bovine inhibin, transforming growth factor-beta and bovine Activin-A on granulosa cell differentiation. Biochem Biophys Res Commun 146 (1987) 1405-1412
72. Chen Y.J., Hsiao P.W., Lee M.T., Mason J.I., Ke F.C., and Hwang J.J. Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells. J Endocrinol 192 (2007) 405-419
73. Johnson A.L., Bridgham J.T., and Woods D.C. Cellular mechanisms and modulation of activin A- and transforming growth factor beta-mediated differentiation in cultured hen granulosa cells. Biol Reprod 71 (2004) 1844-1851
74. Rimler A., Matzkin H., and Zisapel N. Cross talk between melatonin and TGFbeta 1 in human benign prostate epithelial cells. Prostate 40 (1999) 211-217
75. Turgut M., Oktem G., Uslu S., Yurtseven M.E., Aktuǧ H., and Uysal A. The effect of exogenous melatonin administration on trabecular width, ligament thickness and TGF-beta(1) expression in degenerated intervertebral disk tissue in the rat. J Clin Neurosci 13 (2006) 357-363
76. Liu F., Ng T.B., and Fung M.C. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J Neural Transm 108 (2001) 397-405
77. Otsuka F., Yao Z., Lee T., Yamamoto S., Erickson G.F., and Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem 275 (2000) 39523-39528
78. Vitt U.A., Hayashi M., Klein C., and Hsueh A.J. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 62 (2000) 370-377
79. Sugino N., Takiguchi S., Ono M., Tamura H., Shimamura K., Nakamura Y., et al. Nitric oxide concentrations in the follicular fluid and apoptosis of granulosa cells in human follicles. Hum Reprod 11 (1996) 2484-2487
80. Zhang X., Li X.H., Ma X., Wang Z.H., Lu S., and Guo Y.L. Redox-induced apoptosis of human oocytes in resting follicles in vitro. J Soc Gynecol Investig 13 (2006) 451-458
81. Wu R., Van der Hoek K.H., Ryan N.K., Norman R.J., and Robker R.L. Macrophage contributions to ovarian function. Hum Reprod Update 10 (2004) 119-133
82. Halliwell B., and Gutteridge J.M. Free radicals and antioxidant protection: mechanisms and significance in toxicology and disease. Hum Toxicol 7 (1988) 7-13
83. Rapoport R., Sklan D., and Hanukoglu I. Electron leakage from the adrenal cortex mitochondrial P450scc and P450c11 systems: NADPH and steroid dependence. Arch Biochem Biophys 317 (1995) 412-416
84. Gupta R.K., Miller K.P., Babus J.K., and Flaws J.A. Methoxychlor inhibits growth and induces atresia of antral follicles through an oxidative stress pathway. Toxicol Sci 93 (2006) 382-389
85. Tilly J.L., and Tilly K.I. Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles. Endocrinology 136 (1995) 242-252
86. Ratts V.S., Flaws J.A., Kolp R., Sorenson C.M., and Tilly J.L. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 136 (1995) 3665-3668
87. Hsu S.Y., Lai R.J., Finegold M., and Hsueh A.J. Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis. Endocrinology 137 (1996) 4837-4843
88. Matikainen T., Perez G.I., Zheng T.S., Kluzak T.R., Rueda B.R., Flavell R.A., et al. Caspase-3 gene knockout defines cell lineage specificity for programmed cell death signaling in the ovary. Endocrinology 142 (2001) 2468-2480
89. Guha M., Maity P., Choubey V., Mitra K., Reiter R.J., and Bandyopadhyay U. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection. J Pineal Res 43 (2007) 372-381
90. Molpeceres V., Mauriz J.L., García-Mediavilla M.V., González P., Barrio J.P., and González-Gallego J. Melatonin is able to reduce the apoptotic liver changes induced by aging via inhibition of the intrinsic pathway of apoptosis. J Gerontol A Biol Sci Med Sci 62 (2007) 687-695
91. Voordouw B.C., Euser R., Verdonk R.E., Alberda B.T., de Jong F.H., Drogendijk A.C., et al. Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab 74 (1992) 108-117
92. Luboshitzky R., Shen-Orr Z., Shochat T., Herer P., and Lavie P. Melatonin administered in the afternoon decreases next-day luteinizing hormone levels in men: lack of antagonism by flumazenil. J Mol Neurosci 12 (1999) 75-80
93. Luboshitzky R., and Lavie P. Melatonin and sex hormone interrelationships-a review. J Pediatr Endocrinol Metab 12 (1999) 355-362
94. Roy S.K., and Greenwald G.S. In vitro steroidogenesis by primary to antral follicles in the hamster during the periovulatory period: effects of follicle-stimulating hormone, luteinizing hormone, and prolactin. Biol Reprod 37 (1987) 39-46
95. Acosta T.J., Ozawa T., Kobayashi S., Hayashi K., Ohtani M., Kraetzl W.D., et al. Periovulatory changes in the local release of vasoactive peptides, prostaglandin f(2alpha), and steroid hormones from bovine mature follicles in vivo. Biol Reprod 63 (2000) 1253-1261
96. Mitchell L.M., Kennedy C.R., and Hartshorne G.M. Expression of nitric oxide synthase and effect of substrate manipulation of the nitric oxide pathway in mouse ovarian follicles. Hum Reprod 19 (2004) 30-40
97. Murdoch W.J., Peterson T.A., Van Kirk E.A., Vincent D.L., and Inskeep E.K. Interactive roles of progesterone, prostaglandins, and collagenase in the ovulatory mechanism of the ewe. Biol Reprod 35 (1986) 1187-1194
98. Cabeza J., Alarcón-de-la-Lastra C., Jiménez D., Martín M.J., and Motilva V. Melatonin modulates the effects of gastric injury in rats: role of prostaglandins and nitric oxide. Neurosignals 12 (2003) 71-77
99. Konturek S.J., Zayachkivska O., Havryluk X.O., Brzozowski T., Sliwowski Z., Pawlik M., et al. Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves. J Physiol Pharmacol 58 (2007) 361-377
100. Bettahi I., Guerrero J.M., Reiter R.J., and Osuna C. Physiological concentrations of melatonin inhibit the norepinephrine-induced activation of prostaglandin E2 and cyclic AMP production in rat hypothalamus: a mechanism involving inhibiton of nitric oxide synthase. J Pineal Res 25 (1998) 34-40
101. Espey L.L. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 50 (1994) 233-238
102. Nakamura Y., Smith M., Krishna A., and Terranova P.F. Increased number of mast cells in the dominant follicle of the cow: relationships among luteal, stromal, and hilar regions. Biol Reprod 37 (1987) 546-549
103. Brännström M., Mayrhofer G., and Robertson S.A. Localization of leukocyte subsets in the rat ovary during the periovulatory period. Biol Reprod 48 (1993) 277-286
104. Korzekwa A.J., Okuda K., Woclawek-Potocka I., Murakami S., and Skarzynski D.J. Nitric oxide induces apoptosis in bovine luteal cells. J Reprod Dev 523 (2006) 353-361
105. Zuelke K.A., Jones D.P., and Perreault S.D. Glutathione oxidation is associated with altered microtubule function and disrupted fertilization in mature hamster oocytes. Biol Reprod 57 (1997) 1413-1419
106. Kowaltowski A.J., and Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 26 (1999) 463-471
107. Noda Y., Matsumoto H., Umaoka Y., Tatsumi K., Kishi J., and Mori T. Involvement of superoxide radicals in the mouse two-cell block. Mol Reprod Dev 28 (1991) 356-360
108. Paszkowski T., Traub A.I., Robinson S.Y., and McMaster D. Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin Chim Acta 236 (1995) 173-180
109. Yang H.W., Hwang K.J., Kwon H.C., Kim H.S., Choi K.W., and Oh K.S. Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod 13 (1998) 998-1002
110. Paszkowski T., and Clarke R.N. Antioxidative capacity of preimplantation embryo culture medium declines following the incubation of poor quality embryos. Hum Reprod 11 (1996) 2493-2495
111. Sen U., Mukherjee D., Bhattacharyya S.P., and Mukherjee D. Seasonal changes in plasma steroid levels in Indian major carp Labeo rohita: influence of homologous pituitary extract on steroid production and development of oocyte maturational competence. Gen Comp Endocrinol 128 (2002) 123-134
112. Nagahama Y. 17, 20-dihydroxy-4-pregnen-3-one, a maturation-inducing hormone in fish oocytes: mechanisms of synthesis and action. Steroids 62 (1997) 190-196
113. Tokumoto T., Tokumoto M., Horiguchi R., Ishikawa K., and Nagahama Y. Diethylstilbestrol induces fish oocyte maturation. Proc Natl Acad Sci USA 101 (2004) 3686-3690
114. Chattoraj A., Bhattacharyya S., Basu D., Bhattacharya S., Bhattacharya S., and Maitra S.K. Melatonin accelerates maturation inducing hormone (MIH): induced oocyte maturation in carps. Gen Comp Endocrinol 140 (2005) 145-155
115. Korkmaz A., and Reiter R.J. Epigenetic regulation: a new research area for melatonin?. J Pineal Res 44 (2008) 41-44
116. Irmak M.K., and Sizlan A. Essential hypertension seems to result from melatonin-induced epigenetic modifications in area postrema. Med Hypotheses 66 (2006) 1000-1007
117. Irmak M.K., Topal T., and Oter S. Melatonin seems to be a mediator that transfers the environmental stimuli to oocytes for inheritance of adaptive changes through epigenetic inheritance system. Med Hypotheses 64 (2005) 1138-1143
118. Missbach M., Jagher B., Sigg I., Nayeri S., Carlberg C., and Wiesenberg I. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor a with potent antiarthritic activity. J Biol Chem 271 (1996) 13515-13522
119. Smirnov A.N. Nuclear melatonin receptors. Biochemistry (Mosc) 66 (2001) 19-26
120. Ishizuka B., Kuribayashi Y., Murai K., Amemiya A., and Itoh M.T. The effect of melatonin on in vitro fertilization and embryo development in mice. J Pineal Res 28 (2000) 48-51
121. Rodriguez-Osorio N., Kim I.J., Wang H., Kaya A., and Memili E. Melatonin increases cleavage rate of porcine preimplantation embryos in vitro. J Pineal Res 43 (2007) 283-288
122. Abecia J.A., Forcada F., and Zúñiga O. The effect of melatonin on the secretion of progesterone in sheep and on the development of ovine embryos in vitro. Vet Res Commun 26 (2002) 151-158
123. McElhinny A.S., Davis F.C., and Warner C.M. The effect of melatonin on cleavage rate of C57BL/6 and CBA/Ca preimplantation embryos cultured in vitro. J Pineal Res 21 (1996) 44-48
124. Jahnke G., Marr M., Myers C., Wilson R., Travlos G., and Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 50 (1999) 271-279
125. Richards J.S., Russell D.L., Ochsner S., and Espey L.L. Ovulation: new dimensions and new regulators sponse. Annu Rev Physiol 64 (2002) 69-92
126. Natraj U., and Richards J.S. Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology 133 (1993) 761-769
127. Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M., et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91 (1997) 197-208
128. Lydon J.P., DeMayo F.J., Conneely O.M., and O'Malley B.W. Reproductive phenotypes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 56 (1996) 67-77
129. Wetterberg L., Arendt J., Paunier L., Sizonenko P.C., Donselaar W., and Heyden T. Human serum melatonin changes during the menstrual cycle. J Clin Endocrinol Metab 42 (1976) 185-188
130. Brun J., Claustrat B., and David M. Urinary melatonin, LH oestradiol, progesterone excretion during the menstrual cycle or in women taking oral contraceptives. Acta Endocrinol (Copenh) 116 (1987) 145-149
131. Sirotkin A.V. Direct influence of melatonin on steroid, nonapeptide hormones, and cyclic nucleotide secretion by granulosa cells isolated from porcine ovaries. J Pineal Res 17 (1994) 112-117
132. Bódis J., Koppán M., Kornya L., Tinneberg H.R., and Török A. Influence of melatonin on basal and gonadotropin-stimulated progesterone and estradiol secretion of cultured human granulosa cells and in the superfused granulosa cell system. Gynecol Obstet Invest 52 (2001) 198-202
133. Dair E.L., Simoes R.S., Simoes M.J., Gomes Romeu L.R., Oliveira-Filho R.M., Haidar M.A., et al. Effects of melatonin on the endometrial morphology and embryo implantation in rats. Fertil Steril 89 (2008) 1299-1305
134. Freeman M.E., Smith M.S., Nazian S.J., and Neill J.D. Ovarian and hypothalamic control of the daily surges of prolactin secretion during pseudopregnancy in the rat. Endocrinology 94 (1974) 875-882
135. Okuda K., and Sakumoto R. Multiple roles of TNF super family members in corpus luteum function. Reprod Biol Endocrinol 1 (2003) 95-104
136. Webb R., Woad K.J., and Armstrong D.G. Corpus luteum (CL) function: local control mechanisms. Domest Anim Endocrinol 23 (2002) 277-285
137. Wiltbank M.C., and Ottobre J. Regulation of intraluteal production of prostaglandins. Reprod Biol Endocrinol 1 (2003) 91-101
138. Stormshak F. Biochemical and endocrine aspects of oxytocin production by the mammalian corpus luteum. Reprod Biol Endocrinol 1 (2003) 92-97
139. Penny L.A., Armstrong D., Bramley T.A., Webb R., Collins R., and Watson E.D. Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after induced luteolysis. J Reprod Fertil 115 (1999) 87-96
140. Gimeno M.F., Landa A., Sterin-Speziale N., Cardinali D.P., and Gimeno A.L. Melatonin blocks in vitro generation of prostaglandin by the uterus and hypothalamus. Eur J Pharmacol 62 (1980) 309-317
141. Deng W.G., Tang S.T., Tseng H.P., and Wu K.K. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108 (2006) 518-524
142. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Molec Neurobiol 21 (2002) 605-616
143. Juszczak M., and Stempniak B. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies. Brain Res Bull 59 (2003) 393-397
144. Plachot M., Belaisch-Allart J., Mayenga J.M., Chouraqui A., Tesquier A., Serkine A.M., et al. Oocyte and embryo quality in polycystic ovary syndrome. Gynecol Obstet Fertil 31 (2003) 350-354
145. González F., Rote N.S., Minium J., and Kirwan J.P. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91 (2006) 336-340
146. Sabuncu T., Vural H., Harma M., and Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 34 (2001) 407-413
147. Yildirim B., Demir S., Temur I., Erdemir R., and Kaleli B. Lipid peroxidation in follicular fluid of women with polycystic ovary syndrome during assisted reproduction cycles. J Reprod Med 52 (2007) 722-726
148. Sun C.L., Qiao J., Hu Z.X., Zhang T., and Chen Y.Y. Expression of novel apoptosis-related protein PDCD5 in granulosa cells of polycystic ovary syndrome. Beijing Da Xue Xue Bao 37 (2005) 476-479
149. Luboshitzky R., Qupti G., Ishay A., Shen-Orr Z., Futerman B., and Linn S. Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome. Fertil Steril 76 (2001) 506-510
150. Cagnacci A., Soldani R., and Yen S.S.C. Exogenous melatonin enhances luteinizing hormone levels of women in the follicular but not in the luteal menstrual phase. Fertil Steril 63 (1995) 996-999
151. Cagnacci A., Paoletti A.M., Soldani R., Orru' M., Maschio E., and Melis G.B. Melatonin enhances the luteinizing hormone and follicle-stimulating hormone response to gonadotropin-releasing hormone in the follicular, but not in the luteal menstrual phase. J Clin Endocrinol Metab 80 (1995) 1095-1099
152. Cagnacci A., Arangino S., Renzi A., Paoletti A.M., Melis G.B., Cagnacci P., et al. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol 54 (2001) 339-346
153. Prata Lima M.F., Baracat E.C., and Simões M.J. Effects of melatonin on the ovarian response to pinealectomy or continuous light in female rats: similarity with polycystic ovary syndrome. Braz J Med Biol Res 37 (2004) 987-995
154. Auwerx J., and Staels B. Leptin. Lancet 351 (1998) 737-742
155. Houseknecht K.L., Mantzoros C.S., Kuliawat R., Hadro E., Flier J.S., and Kahn B.B. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 45 (1996) 1638-1643
156. Bray G.A., and York D.A. Clinical review 90: leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab 82 (1997) 2771-2776
157. Messinis I.E., and Milingos S.D. Leptin in human reproduction. Hum Reprod Update 5 (1999) 52-63
158. Pasquali R., Gambineri A., and Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 113 (2006) 1148-1159
159. Cervero A., Dominguez F., Horcajadas J.A., Quinonero A., Pellicer A., and Simon C. The role of the leptin in reproduction. Curr Opin Obstet Gynecol 18 (2006) 297-303
160. Li M.G., Ding G.L., Chen X.J., Lu X.P., Dong L.J., Dong M.Y., et al. Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome. J Clin Endocrinol Metab 92 (2007) 4771-4776
161. Fedorcsak P., Storeng R., Dale P.O., Tanbo T., Torjesen P., Urbancsek J., et al. Leptin and leptin binding activity in the preovulatory follicle of polycystic ovary syndrome patients. Scand J Clin Lab Invest 60 (2000) 649-656
162. Cioffi J.A., Van Blerkom J., Antczak M., Shafer A., Wittmer S., and Snodgrass H.R. The expression of leptin and its receptors in pre-ovulatory human follicles. Mol Hum Reprod 3 (1997) 467-472
163. Brannian J.D., Zhao Y., and McElroy M. Leptin inhibits gonadotrophin-stimulated granulosa cell progesterone production by antagonizing insulin action. Hum Reprod 14 (1999) 1445-1448
164. Wolden-Hanson T., Mitton D.R., McCants R.L., Yellon S.M., Wilkinson C.W., Matsumoto A.M., et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 141 (2000) 487-497
165. Canpolat S., Sandal S., Yilmaz B., Yasar A., Kutlu S., Baydas G., et al. Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rat. Eur J Pharmacol 428 (2001) 145-148
166. Alonso-Vale M.I., Andreotti S., Peres S.B., Anhê G.F., das Neves Borges-Silva C., Neto J.C., et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 288 (2005) E805-E812
167. Brydon L., Petit L., Delagrange P., Strosberg A.D., and Jockers R. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology 142 (2001) 4264-4271
168. Mahmood T.A., and Templeton A. Prevalence and genesis of endometriosis. Hum Reprod 6 (1991) 544-549
169. Rawson J.M. Prevalence of endometriosis in asymptomatic women. J Reprod Med 36 (1991) 513-515
170. Sangi-Haghpeykar H., and Poindexter III A.N. Epidemiology of endometriosis among parous women. Obstet Gynecol 85 (1995) 983-992
171. Van Langendonckt A., Casanas-Roux F., and Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril 77 (2002) 861-870
172. Zeller J.M., Henig I., Radwanska E., and Dmowski W.P. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol 13 (1987) 78-82
173. Osborn B.H., Haney A.F., Misukonis M.A., and Weinberg J.B. Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility. Fretil Steril 77 (2002) 46-51
174. Ozçelik B., Serin I.S., Basbug M., Uludag S., Narin F., and Tayyar M. Effect of melatonin in the prevention of post-operative adhesion formation in a rat uterine horn adhesion model. Hum Reprod 18 (2003) 1703-1706
175. Güney M., Oral B., Karahan N., and Mungan T. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril 89 (2008) 934-942
176. Paul S., Sharma A.V., Mahapatra P.D., Bhattacharya P., and Swarnakar S. Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 44 (2008) 439-449
177. Coulam C.B., Adamson D.C., and Annegers J.F. Incidence of premature ovarian failure. Obstet Gynecol 67 (1986) 604-606
178. Nelson L.M., Covington S.N., and Rebar R.W. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 83 (2005) 1327-1332
179. Larsen E.C., Muller J., Schmiegelow K., Rechnitzer C., and Andersen A.N. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88 (2003) 5307-5314
180. Vijayalaxmi, Reiter R.J., Tan D.X., Herman T.S., and Thomas Jr. C.R. Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys 59 (2004) 639-653
181. Schuck A., Hamelmann V., Brämswig J.H., Könemann S., Rübe C., Hesselmann S., et al. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol 181 (2005) 534-539
182. Gosden R.G., Wade J.C., Fraser H.M., Sandow J., and Faddy M.J. Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Hum Reprod 12 (1997) 2483-2488
183. Shirazi A., Ghobadi G., and Ghazi-Khansari M. A radiobiological review on melatonin: a novel radioprotector. J Radiat Res (Tokyo) 48 (2007) 263-272
184. Badr F.M., El Habit O.H., and Harraz M.M. Radioprotective effect of melatonin assessed by measuring chromosomal damage in mitotic and meiotic cells. Mutat Res 444 (1999) 367-372
185. Koc M., Taysi S., Emin Buyukokuroglu M., and Bakan N. The effect of melatonin against oxidative damage during total-body irradiation in rats. Radiat Res 160 (2003) 251-255
186. Familiari G., Caggiati A., Nottola S.A., Ermini M., Di Benedetto M.R., and Motta P.M. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 8 (1993) 2080-2087
187. Lissoni P., Barni S., Mandalà M., Ardizzoia A., Paolorossi F., Vaghi M., et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer 35 (1999) 1688-1692
188. Reiter R.J., Tan D.X., Sainz R.M., Mayo J.C., and Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 54 (2002) 1299-1321
189. Oz E., Erbaş D., Sürücü H.S., and Düzgün E. Prevention of doxorubicin-induced cardiotoxicity by melatonin. Mol Cell Biochem 282 (2006) 31-37
190. Reiter R.J., Tan D.X., Sainz R.M., and Mayo J.C. Melatonin protects the heart against both ischemia/reperfusion injury and chemotherapeutic drugs. Cardiovasc Drugs Ther 16 (2002) 5-6
191. Conway G.S. Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol (Oxf) 45 (1996) 657-663
192. Narayanan M., Murthy P.S., Munaf S.A., Shah L.C., and Kini M.D. Antiovarian antibodies and their effect on the outcome of assisted reproduction. J Assist Reprod Genetics 12 (1995) 599-605
193. Nandedkar T.D., and Wadia P. Autoimmune disorders of the ovary. Indian J Exper Biol 36 (1998) 433-436
194. Luborsky J., Llanes B., Davies S., Binor Z., Radwanska E., and Pong R. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol 90 (1999) 368-374
195. Nelson L.M., Kimzey L.M., Merriam G.R., and Fleisher T.A. Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. Fertil Steril 55 (1991) 1082-1087
196. Monnier-Barbarino P., Forges T., Faure G.C., and Bene M.C. Gonadal antibodies interfering with female reproduction. Best Pract Res Clin Endocrinol Metab 19 (2005) 135-148
197. Drexhage H.A., Bottazzo G.F., Bitensky L., Chayen J., and Doniach D. Thyroid growth-blocking antibodies in primary myxoedema. Nature 289 (1981) 594-596
198. Guerrero J.M., and Reiter R.J. Melatonin-immune system relationships. Curr Top Med Chem 2 (2002) 167-179
199. Carrillo-Vico A., García-Mauriño S., Calvo J.R., and Guerrero J.M. Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J 17 (2003) 755-777
200. García-Pergañeda A., Pozo D., Guerrero J.M., and Calvo J.R. Signal transduction for melatonin in human lymphocytes: Involvement of a pertussis-toxin sensitive G protein. J Immunol 159 (1997) 3774-3781
201. Barjavel M.J., Mamdouh Z., Raghbate N., and Bakouche O. Differential expression of the melatonin receptor in human monocytes. J Immunol 160 (1998) 1191-1197
202. Srinivasan V., Maestroni G.J., Cardinali D.P., Esquifino A.I., Perumal S.R., and Miller S.C. Melatonin, immune function and aging. Immun Ageing 2 (2005) 17
203. Petrovsky N., and Harrison L. The chronobiology of human cytokine production. Int Rev Immunol 16 (1998) 635-649
204. Raghavendra V., Singh V., Kulkarni S.K., and Agrewala J.N. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem 221 (2001) 57-62
205. Kang J.C., Ahn M., Kim Y.S., Moon C., Lee Y., Wie M.B., et al. Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1. J Vet Sci 2 (2001) 85-89
206. Voznesenskaya T., Makogon N., Bryzgina T., Sukhina V., Grushka N., and Alexeyeva I. Melatonin protects against experimental immune ovarian failure in mice. Reprod Biol 7 (2007) 207-220
207. Buscemi N., Vandermeer B., Hooton N., Pandya R., Tjosvold L., Hartling L., et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 332 (2006) 385-393
208. Jan J.E., Wasdell M.B., Reiter R.J., Weiss M.D., Johnson K.P., Ivanenko A., et al. Melatonin in therapy at pediatric sleep disorders: recent advances, why it works, who are the candidates and how to treat. Curr Pediatr Rev 3 (2007) 214-224